CEI Today: TSA body scanners, FDA over-regulation, and a court ruling on drug manufacturers
TSA BODY SCANNERS - MARC SCRIBNER
The Transportation Security Administration (TSA) should be compelled to at last give the public an opportunity to comment on the agency’s use of full-body scanners in airports, a new brief of amici curiae by the Competitive Enterprise Institute (CEI) urges. For more than three years, TSA’s use of body-scanners has affected millions of Americans, yet passengers still have had no opportunity to formally voice their concerns to the agency.
FDA OVER-REGULATION - MICHELLE MINTON
News outlets are reporting that the U.S. Food and Drug Administration (FDA) has cited an alarmingly high number of alleged safety and regulatory violations by supplement manufacturers. This may worry some consumers about the safety of their daily multivitamin. It has also prompted some lawmakers to call, once again, for increasing the FDA's control over the supplement industry. While there is no reason to doubt that the FDA found violations of rules in its investigation, more government regulation would do nothing to improve the safety of America's vitamin supply.
DRUG MANUFACTURERS - GREG CONKO
The U.S. Court of Appeals for the Third Circuit handed down a decision on Monday holding that reverse payment - or so-called "pay to delay" - patent settlement agreements between innovator and generic drug manufacturers may constitute antitrust violations.
That decision sets up a Circuit split that now seems ripe for Supreme Court review, as the Federal Circuit, Second Circuit, and Eleventh Circuit appeals courts have previously ruled that, in most cases, these settlement agreements are not anticompetitive.
Congress will soon vote on a package of reforms for holders of the H-1B visa for high-skilled immigrants. Policy Analyst David Bier unpacks the proposed reforms, and explains why allowing more high-skilled immigration would help spark economic growth, especially in the technology sector.